UBS Lux Equity Fund Biotech USD vs Xact Sverige

UBS Lux Equity Fund Biotech USD vs Xact Sverige

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. Xact Sverige

  • Security

    Xact Sverige UCITS ETF

  • Fee

    0.15%

  • ISIN

    SE0001056045

  • Holdings

    25

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Xact Sverige, we have 32 holdings where Atlas Copco is the largest holding (7.48), followed by Investor (6.89) and Volvo (5.83).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Xact Sverige.

UBS Lux Equity Fund Biotech USD Xact Sverige
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Atlas Copco A
Sweden
7.48 %
2. Moderna Inc
9.21 %
2. Investor B
Sweden
6.89 %
3. Gilead Sciences Inc
USA
4.66 %
3. Volvo B
Sweden
5.83 %
4. BioNTech SE
4.13 %
4. EQT AB
Sweden
5.41 %
5. Karuna Therapeutics Inc
3.75 %
5. Investor A
Sweden
4.72 %
- 6. Assa Abloy B
Sweden
4.3 %
- 7. SEB A
Sweden
3.9 %
- 8. Sandvik
Sweden
3.45 %
- 9. Swedbank A
Sweden
3.27 %
- 10. ABB Ltd
Sweden Switzerland
3.27 %
- 11. Ericsson B
Sweden
3.1 %
- 12. Atlas Copco B
Sweden
3.09 %
- 13. AstraZeneca
Sweden UK
2.93 %
- 14. Handelsbanken A
Sweden
2.86 %
- 15. Hennes & Mauritz B
Sweden
2.51 %
- 16. Alfa Laval
Sweden
2.45 %
- 17. Essity B
Sweden
2.16 %
- 18. Epiroc A
Sweden
2.09 %
- 19. Volvo A
Sweden
1.63 %
- 20. Telia Company AB
Sweden
1.53 %
- 21. Swedish Orphan Biovitrum AB
Sweden
1.43 %
- 22. Indutrade AB
Sweden
1.33 %
- 23. SCA B
Sweden
1.17 %
- 24. Nordea Bank Abp
Finland
1.16 %
- 25. SKF B
Sweden
1.15 %

The list of fund holdings was last updated on September 10, 2025.